Outcomes in Patients With Immune Checkpoint Inhibitor-Related Myopathy and Prolonged Follow-Up.

Segal Y, Mangioris G, Toledano M, Kottschade L, Flanagan EP, McKeon A, Stoff R, Naddaf E, Pittock SJ, Dubey D, Zekeridou A.